Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

A new tool to assess Clinical Diversity In Meta-analyses (CDIM) of interventions

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effect Modifiers and Statistical Tests for Interaction in Randomized Trials

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Evidence-Based Research Series-Paper 1: What Evidence-Based Research is and why is it important?

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  4. Evidence-Based Research Series-Paper 2: Using an Evidence-Based Research approach before a new study is conducted to ensure value

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: To develop and validate Clinical Diversity In Meta-analyses (CDIM), a new tool for assessing clinical diversity between trials in meta-analyses of interventions.

STUDY DESIGN AND SETTING: The development of CDIM was based on consensus work informed by empirical literature and expertise. We drafted the CDIM tool, refined it, and validated CDIM for interrater scale reliability and agreement in three groups.

RESULTS: CDIM measures clinical diversity on a scale that includes four domains with 11 items overall: setting (time of conduct/country development status/units type); population (age; sex; patient inclusion criteria/baseline disease severity, comorbidities); interventions (intervention intensity/strength/duration of intervention; timing; control intervention; cointerventions);and outcome (definition of outcome; timing of outcome assessment). The CDIM is completed in two steps: first two authors independently assess clinical diversity in the four domains. Second, after agreeing upon scores of individual items a consensus score is achieved. Interrater scale reliability and agreement ranged from moderate to almost perfect depending on the type of raters.

CONCLUSION: CDIM is the first tool developed for assessing clinical diversity in meta-analyses of interventions. We found CDIM to be a reliable tool for assessing clinical diversity among trials in meta-analysis.

OriginalsprogEngelsk
TidsskriftJournal of Clinical Epidemiology
Vol/bind135
Sider (fra-til)29-41
Antal sider13
ISSN0895-4356
DOI
StatusE-pub ahead of print - 6 feb. 2021

ID: 62238157